搜索
NewAmsterdam Pharma Company NV
NAMSW添加自选
24.890USD
+1.450+6.19%
收盘 07/07, 16:00（美东）报价延迟15分钟
0.00总市值
--市盈率 TTM
关于 NewAmsterdam Pharma Company NV 公司
NewAmsterdam Pharma Company NV 是一家荷兰公司。NewAmsterdam Pharma 是一家临床阶段公司，专注于研究和开发用于治疗主要心脏代谢疾病的变革性口服疗法。该公司正在研究 obicetrapib，一种口服、低剂量、每日一次的胆固醇酯转移蛋白 (CETP) 抑制剂，作为低密度脂蛋白胆固醇 (LDL-C) 降低疗法，用作高风险心血管疾病 (CVD) 患者的辅助他汀类药物疗法。该公司还在第二阶段 2 期试验 ROSE2 中测试 obicetrapib 与依折麦布的固定剂量联合疗法，用于治疗阿尔茨海默病等其他疾病。该公司致力于在全球范围内提供其产品。
NewAmsterdam Pharma Company NV简介
公司代码NAMSW
公司名称NewAmsterdam Pharma Company NV
上市日期Nov 23, 2022
CEODr. Michael Harvey Davidson, M.D.
员工数量- -
证券类型Company Warrant
年结日- -
公司地址Gooimeer 2-35
城市NAARDEN
上市交易所NASDAQ Global Market Consolidated
国家Netherlands
邮编1411 DC
电话31352062971
网址https://ir.newamsterdampharma.com/
公司代码NAMSW
上市日期Nov 23, 2022
CEODr. Michael Harvey Davidson, M.D.
NewAmsterdam Pharma Company NV公司高管
名称
名称/职务
职务
持股
持股变动
Mr. William H. (Will) Lewis, J.D.
Mr. William H. (Will) Lewis, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Mark C. Mckenna
Mr. Mark C. Mckenna
Independent Director
Independent Director
--
--
Mr. Wouter Joustra
Mr. Wouter Joustra
Independent Director
Independent Director
--
--
Ms. Adele M. Gulfo
Ms. Adele M. Gulfo
Independent Director
Independent Director
--
--
Dr. Louis Lange, M.D., Ph.D.
Dr. Louis Lange, M.D., Ph.D.
Independent Director
Independent Director
--
--
Ms. Janneke Van Der Kamp
Ms. Janneke Van Der Kamp
Temporary Non-Executive Director
Temporary Non-Executive Director
--
--
Dr. James N. Topper, M.D., Ph.D.
Dr. James N. Topper, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Nicholas Downing, M.D.
Dr. Nicholas Downing, M.D.
Director
Director
--
--
Ms. Louise Kooij
Ms. Louise Kooij
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Dr. Michael Harvey Davidson, M.D.
Dr. Michael Harvey Davidson, M.D.
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. William H. (Will) Lewis, J.D.
Mr. William H. (Will) Lewis, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Mark C. Mckenna
Mr. Mark C. Mckenna
Independent Director
Independent Director
--
--
Mr. Wouter Joustra
Mr. Wouter Joustra
Independent Director
Independent Director
--
--
Ms. Adele M. Gulfo
Ms. Adele M. Gulfo
Independent Director
Independent Director
--
--
Dr. Louis Lange, M.D., Ph.D.
Dr. Louis Lange, M.D., Ph.D.
Independent Director
Independent Director
--
--
Ms. Janneke Van Der Kamp
Ms. Janneke Van Der Kamp
Temporary Non-Executive Director
Temporary Non-Executive Director
--
--
常见问题
NewAmsterdam Pharma Company NV的前五大股东是谁？
NewAmsterdam Pharma Company NV 的前五大股东如下：Mr. William H. (Will) Lewis, J.D.